Quantedge Capital Pte Ltd Has $1.95 Million Stock Holdings in BlackRock Health Sciences Term Trust $BMEZ

Quantedge Capital Pte Ltd boosted its stake in shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) by 85.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 135,854 shares of the company’s stock after purchasing an additional 62,400 shares during the quarter. BlackRock Health Sciences Term Trust comprises approximately 1.1% of Quantedge Capital Pte Ltd’s investment portfolio, making the stock its 21st biggest position. Quantedge Capital Pte Ltd’s holdings in BlackRock Health Sciences Term Trust were worth $1,951,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Kestra Advisory Services LLC bought a new position in shares of BlackRock Health Sciences Term Trust in the fourth quarter valued at about $26,000. SouthState Bank Corp bought a new stake in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth about $29,000. PNC Financial Services Group Inc. bought a new stake in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth about $35,000. Geneos Wealth Management Inc. acquired a new position in BlackRock Health Sciences Term Trust in the 1st quarter valued at about $40,000. Finally, Allworth Financial LP grew its stake in BlackRock Health Sciences Term Trust by 24,584.6% in the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after buying an additional 3,196 shares during the last quarter.

BlackRock Health Sciences Term Trust Price Performance

BlackRock Health Sciences Term Trust stock opened at $15.30 on Wednesday. BlackRock Health Sciences Term Trust has a twelve month low of $13.67 and a twelve month high of $15.80. The company’s 50-day moving average price is $14.75 and its two-hundred day moving average price is $14.72.

BlackRock Health Sciences Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Tuesday, September 15th will be given a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, September 15th. This represents a c) annualized dividend and a dividend yield of 8.6%.

BlackRock Health Sciences Term Trust Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.